{"transactions":[{"id":2209204,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T19:54:25.000Z","date":"2022-07-01","kind":"tax_withholding","acquired":false,"shares":32082,"price":1.12,"value":35931.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\")."}],"balance_after":1687986,"source":{"system":"sec-edgar","filing":"0001601485-22-000059","document":"wf-form4_165758365151556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000160148522000059/wf-form4_165758365151556.xml","form_type":"4"}},{"id":2482246,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-07T16:06:40.000Z","date":"2021-12-06","kind":"sale","acquired":false,"shares":32118,"price":3.3539,"value":107720.5602,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.21 to $3.45 inclusive."}],"balance_after":1720068,"source":{"system":"sec-edgar","filing":"0001601485-21-000081","document":"wf-form4_163891118480825.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000160148521000081/wf-form4_163891118480825.xml","form_type":"4"}},{"id":2485850,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-03T18:03:34.000Z","date":"2021-12-03","kind":"sale","acquired":false,"shares":40215,"price":3.3872,"value":136216.248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.29 to $3.50 inclusive."}],"balance_after":1752186,"source":{"system":"sec-edgar","filing":"0001601485-21-000079","document":"wf-form4_163857259870004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000160148521000079/wf-form4_163857259870004.xml","form_type":"4"}},{"id":2485849,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-03T18:03:34.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":38800,"price":3.5136,"value":136327.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.36 to $3.64 inclusive."}],"balance_after":1792401,"source":{"system":"sec-edgar","filing":"0001601485-21-000079","document":"wf-form4_163857259870004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000160148521000079/wf-form4_163857259870004.xml","form_type":"4"}},{"id":2485848,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-12-03T18:03:34.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":38867,"price":3.542,"value":137666.914,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.31 to $3.79 inclusive."}],"balance_after":1831201,"source":{"system":"sec-edgar","filing":"0001601485-21-000079","document":"wf-form4_163857259870004.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000160148521000079/wf-form4_163857259870004.xml","form_type":"4"}},{"id":2507276,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-17T18:02:23.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":38495,"price":4.2553,"value":163807.7735,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.21 to $4.38 inclusive."}],"balance_after":1870068,"source":{"system":"sec-edgar","filing":"0001601485-21-000075","document":"wf-form4_163719012500153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000160148521000075/wf-form4_163719012500153.xml","form_type":"4"}},{"id":2507275,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-17T18:02:23.000Z","date":"2021-11-15","kind":"sale","acquired":false,"shares":111505,"price":4.1724,"value":465243.462,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares reported in this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2021 by the Reporting Person"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.48 inclusive."}],"balance_after":1908563,"source":{"system":"sec-edgar","filing":"0001601485-21-000075","document":"wf-form4_163719012500153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000160148521000075/wf-form4_163719012500153.xml","form_type":"4"}},{"id":2507274,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-11-17T18:02:23.000Z","date":"2021-06-24","kind":"tax_withholding","acquired":false,"shares":47410,"price":13.78,"value":653309.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units (\"RSUs\")."}],"balance_after":2020068,"source":{"system":"sec-edgar","filing":"0001601485-21-000075","document":"wf-form4_163719012500153.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000160148521000075/wf-form4_163719012500153.xml","form_type":"4"}},{"id":2866642,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-11T19:23:04.000Z","date":"2021-02-09","kind":"tax_withholding","acquired":false,"shares":38353,"price":16,"value":613648.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of  Restricted Stock Units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 239,912 RSUs. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof."}],"balance_after":2067478,"source":{"system":"sec-edgar","filing":"0001567619-21-003190","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000156761921003190/doc1.xml","form_type":"4"}},{"id":2874471,"issuer":{"id":299,"kind":"organization","name":"Elicio Therapeutics, Inc.","symbol":"ELTX"},"owners":[{"id":125451,"kind":"person","name":"Goldberg Itzhak","position":1,"cik":"0001607858","reported_name":"Goldberg Itzhak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-08T12:58:27.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":70012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares vest in forty-eight (48) successive and equal monthly installments measured from February 4, 2021 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":70012,"derivative":{"exercise_price":16,"expiration_date":"2031-02-03","underlying":"Common Stock","underlying_shares":70012},"source":{"system":"sec-edgar","filing":"0001567619-21-002412","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1607858/000156761921002412/doc1.xml","form_type":"4"}}]}